Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

An 18-year-old man was diagnosed with a rare genetic disorder causing hair loss, severe light sensitivity, and skin issues.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Apremilast did not work for treating severe alopecia areata.

A homeopathic antidandruff shampoo caused severe hair matting in a girl.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia Areata might be linked to Crohn's disease.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

A new mouse model for vitiligo helps study immune responses and potential treatments.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Inhibiting TYK2 can restore hair growth in alopecia areata.